UK Clinical Chemistry and Immunodiagnostics Markets: A 2011 Report by Venture Planning Group

Oct. 5, 2011 - PRLog -- Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce completion of a new 563-page report, “The 2011 UK Clinical Chemistry and Immunodiagnostics Markets"
(http://www.vpgmarketresearch.com/clinical-chemistry). The report is designed to help current suppliers and potential market entrants identify and evaluate major opportunities emerging in the UK clinical chemistry and immunodiagnostics market during this decade.

This report presents a comprehensive analysis of the UK clinical chemistry and immunodiagnostics markets, including:
•Major issues pertaining to the UK clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
•Five- and ten-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in UK hospitals and commercial laboratories, including controls, calibrators and consumables.
•Five- and ten-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
•Five- and ten-year reagent and instrument sales forecasts.
•Review of current instrumentation technologies, and a feature comparison of 50 high-, medium-, and low-volume/POC analyzers.
•Sales and market shares of leading reagent and instrument suppliers.
•Review of current and emerging technologies and their potential market applications.
•Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.
•Profiles of 25 current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
•Market penetration strategies, entry barriers and risks.

Contains 563 pages and 103 tables .

To review or order this report, please visit http://www.vpgmarketresearch.com/uk-clinical-chemistry-an...

Contact

Robert Fisher
Healthcare Research
robert@vpgcorp.com
+1 212 564 2838
http://www.VPGMarketResearch.com

# # #

Venture Planning Group is an international market research, publishing and management consulting firm providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavor & Fragrance, Food & Beverage, Electronics and other industries.

During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide.

VPG has served over 1,000 corporations in 70 countries, and has established a worldwide network of contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government.

Specialties
Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/Joint Venture Evaluations.